The {pharmaceutical market is increasingly exploring novel treatment approaches for obesity , and the emergence of semaglutide 10mg injectables represents the development . Clinicians are cautiously consider the possible benefits and drawbacks associated with this higher potency product, notably in comparison to existing lower-dose semaglutide prod